经前障碍症状与重性精神疾病多基因风险的关联
该遗传关联研究纳入挪威母婴队列中56 725名妊娠15周女性,采用多基因风险评分(PRS)分析经前障碍症状与重性精神疾病遗传易感性的关联。结果显示经前障碍症状与重性抑郁、双相障碍、精神分裂症、注意缺陷/多动障碍及孤独症谱系障碍的PRS均相关,而与身高PRS无关,提示经前障碍与重性精神疾病存在重叠的遗传基础。
要点
- 经前障碍症状与重性抑郁、双相障碍、精神分裂症、ADHD及ASD的PRS相关。
- 经前障碍症状与身高PRS无关,提示关联具有精神疾病特异性。
- 在无精神疾病史亚组中结果仍成立,支持遗传重叠独立于既往诊断。
核心结论
- 经前障碍症状与情感谱系及重性精神疾病的遗传易感性相关,提示二者存在重叠的遗传基础。
研究设计与样本
- 遗传关联研究,纳入挪威母婴队列研究1999年6月至2008年12月招募的56 725名女性,分析于2022年7月1日至10月14日进行。
- 经前障碍症状在妊娠15周招募时通过自报经前抑郁和易激惹严重程度评估。
- 采用多基因风险评分(PRS)评估重性抑郁、双相障碍、精神分裂症、注意缺陷/多动障碍、孤独症谱系障碍的遗传易感性,以身高PRS作为体细胞对照。
主要发现
- 56 725名女性平均(SD)年龄29.0(4.6)岁,12 316名(21.7%)存在经前障碍症状。
- 经前障碍症状与重性抑郁PRS相关(β=0.13;95%CI 0.11-0.15;P=1.21×10-36)。
- 经前障碍症状与双相障碍PRS相关(β=0.07;95%CI 0.05-0.09;P=1.74×10-11)。
- 经前障碍症状与注意缺陷/多动障碍PRS相关(β=0.07;95%CI 0.04-0.09;P=1.58×10-9)。
- 经前障碍症状与精神分裂症PRS相关(β=0.11;95%CI 0.09-0.13;P=7.61×10-25)。
关键数值与推荐
- 经前障碍症状与重性抑郁、双相障碍、精神分裂症、ADHD及ASD的PRS显著相关,与身高PRS无显著关联。
- 在无精神疾病诊断史的亚组中,上述关联得到验证。
临床怎么用
- 对经前障碍症状患者,临床评估时应注意其情感谱系及重性精神疾病遗传易感性的可能重叠。
- 遗传易感性不能替代临床诊断,但提示经前障碍症状可能作为精神疾病风险筛查的线索之一。
局限性
- 经前障碍症状基于妊娠15周时自报的经前抑郁和易激惹严重程度,非临床诊断。
- 样本为挪威妊娠女性,结果外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Premenstrual disorders are heritable, clinically heterogenous, with a range of affective spectrum comorbidities. It is unclear whether genetic predispositions to affective spectrum disorders or other major psychiatric disorders are associated with symptoms of premenstrual disorders. OBJECTIVE: To assesss whether symptoms of premenstrual disorders are associated with the genetic liability for major psychiatric disorders, as indexed by polygenic risk scores (PRSs). DESIGN, SETTING, AND PARTICIPANTS: Women from the Norwegian Mother, Father and Child Cohort Study were included in this genetic association study. PRSs were used to determine whether genetic liability for major depression, bipolar disorder, schizophrenia, attention-deficit/hyperactivity disorder, and autism spectrum disorder were associated with the symptoms of premenstrual disorders, using the PRS for height as a somatic comparator. The sample was recruited across Norway between June 1999 and December 2008, and analyses were performed from July 1 to October 14, 2022. MAIN OUTCOMES AND MEASURES: The symptoms of premenstrual disorders were assessed at recruitment at week 15 of pregnancy with self-reported severity of depression and irritability before menstruation. Logistic regression was applied to test for the association between the presence of premenstrual disorder symptoms and the PRSs for major psychiatric disorders. RESULTS: The mean (SD) age of 56 725 women included in the study was 29.0 (4.6) years. Premenstrual disorder symptoms were present in 12 316 of 56 725 participants (21.7%). The symptoms of premenstrual disorders were associated with the PRSs for major depression (β = 0.13; 95% CI, 0.11-0.15; P = 1.21 × 10-36), bipolar disorder (β = 0.07; 95% CI, 0.05-0.09; P = 1.74 × 10-11), attention deficit/hyperactivity disorder (β = 0.07; 95% CI, 0.04-0.09; P = 1.58 × 10-9), schizophrenia (β = 0.11; 95% CI, 0.09-0.13; P = 7.61 × 10-25), and autism spectrum disorder (β = 0.03; 95% CI, 0.01-0.05; P = .02) but not with the PRS for height. The findings were confirmed in a subsample of women without a history of psychiatric diagnosis. CONCLUSIONS: The results of this genetic association study show that genetic liability for both affective spectrum disorder and major psychiatric disorders was associated with symptoms of premenstrual disorders, indicating that premenstrual disorders have overlapping genetic foundations with major psychiatric disorders.
引用
- Jaholkowski P, Shadrin AA, Jangmo A, et al. Associations Between Symptoms of Premenstrual Disorders and Polygenic Liability for Major Psychiatric Disorders. JAMA Psychiatry. 2023. PMID: 37163253. doi:10.1001/jamapsychiatry.2023.1137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。